Ísrael - hebreska - Ministry of Health

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 100 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

Ísrael - hebreska - Ministry of Health

glaxo smith kline (israel) ltd - amoxicillin as trihydrate; clavulanic acid as potassium salt - אבקה להכנת תרחיף - amoxicillin as trihydrate 600 mg / 5 ml; clavulanic acid as potassium salt 42.9 mg / 5 ml - amoxicillin and enzyme inhibitor - amoxicillin and enzyme inhibitor - augmentin es is indicated for the treatment of acute otitis media in children aged at least 3 months and less than 40 kg body weight, caused or thought likely to be caused by penicillin-resistant streptococcus pneumoniae:consideration should be given to official guidance on the appropriate use of antibacterial agents.

Ísrael - hebreska - Ministry of Health

j-c health care ltd - doripenem 500 mg - powder for solution for infusion - doripenem - doribax is indicated for the treatment of the following infections in adults : - complicated intra-abdominal infections - complicated urinary tract infections. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ceftaroline fosamil - אבקה להכנת תמיסה מרוכזת לעירוי - ceftaroline fosamil 600 mg - ceftaroline fosamil - ceftaroline fosamil - zinforo is indicated in adults for the treatment of the following infections: • complicated skin and soft tissue infections (cssti)• community-acquired pneumonia (cap) consideration should be given to official guidance on the appropriate use of antibacterial agents.

Ísrael - hebreska - Ministry of Health

neopharm scientific ltd - a/california/7/2009 (h1n1) 7.5 mcg / 0.5 ml - suspension for injection - influenza, inactivated, whole virus - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Ísrael - hebreska - Ministry of Health

neopharm scientific ltd - a/california/7/2009 (h1n1) 7.5 mcg / 0.5 ml - suspension for injection - influenza, inactivated, whole virus - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Ísrael - hebreska - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Ísrael - hebreska - Ministry of Health

glaxo smith kline (israel) ltd - a/california/7/2009 (h1n1)v nymc x-179a 3.75 mcg / 0.25 ml - suspension for injection - prophylaxis of influenza in an officially declared pandemic situation.pandemic influenza vaccine should be used in accordance with official guidance.

Ísrael - hebreska - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine

Ísrael - hebreska - Ministry of Health

eli lilly israel ltd, israel - ixekizumab - תמיסה להזרקה - ixekizumab 80 mg / 1 ml - ixekizumab